Q1 2025 Pediatrix Medical Group Inc Earnings Call Transcript
Key Points
- Pediatrix Medical Group Inc (MD) exceeded expectations with a same unit revenue growth of over 6% in the first quarter.
- Adjusted EBITDA was significantly above expectations at just over $49 million, leading to an increased full-year 2025 adjusted EBITDA outlook.
- The company successfully implemented cost management initiatives, resulting in decelerated expense trends for the fourth consecutive quarter.
- Pediatrix Medical Group Inc (MD) reported strong cash collections and improved accounts receivable days outstanding, enhancing cash flow.
- The company is actively engaged in strengthening relationships with hospital and health system partners, leading to new contracts and potential growth opportunities.
- Consolidated revenue decreased by over 7% due to non-same-unit activity, primarily from portfolio restructuring impacts.
- Operating cash flow was negative in the first quarter, with $116 million used, primarily due to incentive compensation and benefits payouts.
- There is ongoing uncertainty in the healthcare sector and the broader economy, leading to a conservative stance on future guidance.
- The company faces challenging comparisons for the remainder of 2025, which may impact future performance metrics.
- Despite improvements, the accounts receivable days outstanding remain elevated, indicating potential challenges in collections.
-- certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by Pediatrix management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.
Any forward-looking statements made during this call are made as of today, and Pediatrix undertakes no duty to update or revise any such statements, whether as a result of new information, future events, or otherwise. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the company's filings with the SEC, including the sections entitled Risk Factors.
In today's remarks by management, we will be discussing non-GAAP financial metrics. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
